Brainomix specializes in advanced imaging technologies aimed at improving the diagnosis and treatment of neurological conditions, particularly stroke. Their flagship product, e-ASPECTS, utilizes artificial intelligence to analyze brain scans and provide rapid assessments of ischemic stroke. This technology enhances the decision-making process for clinicians by delivering accurate and timely information, which is crucial for effective patient management. Additionally, Brainomix is focused on developing solutions that integrate seamlessly into existing clinical workflows, ensuring that healthcare professionals can leverage these tools without significant disruption.

The company is also dedicated to advancing the field of neuroimaging through ongoing research and development. Their technologies are designed to support personalized medicine by enabling more precise identification of patient needs and treatment responses. By harnessing the power of machine learning and data analytics, Brainomix aims to transform the landscape of stroke care, ultimately improving patient outcomes and optimizing healthcare resources. Their commitment to innovation in neuroimaging positions them as a leader in the intersection of technology and healthcare.

United Kingdom

We turn ordinary scans into extraordinary insights because every patient deserves expert-level care, anywhere.

Impactful. Scalable. Smart. Brainomix 360 enhances stroke imaging interpretation for neurologists, interventionalists, and radiologists while seamlessly fitting into existing radiology workflows. Delivering the right insights, to the right people, at the right time.

Since our 2010 spin-out from the University of Oxford, we've developed award-winning, AI-powered imaging biomarkers and software solutions that empower physicians worldwide to make critical, life-saving decisions in stroke and lung care.

Brainomix

Company Details